Désolé, cet article est seulement disponible en Anglais Américain.
Cliquez pour voir le graph
Connexions
Cliquez pour voir la ligne de temps
Ligne de temps
Cours
MOOC on biomarker
Biomarkers are the subject of considerable interest by scientists and researchers worldwide: they determine the use of targeted treatments (a major therapeutic advance in medicine), allow to measure the evolution of a disease or […]
2017-05-29 09:00:00
2017-07-12 18:00:00
Europe/Paris
MOOC on biomarker
Biomarkers are the subject of considerable interest by scientists and researchers worldwide: they determine the use of targeted treatments (a major therapeutic advance in medicine), allow to measure the evolution of a disease or […]
Institut Pasteur, Rue du Docteur Roux, Paris, France
Projets
CV
(EN)
Medico-Scientific Career
- MD, University Paris Descartes (1983) : hepatitis B virus occult infections
- PhD, University Paris VII (1992) : regulation of iso-enzymes of ALT in liver disease
- HDR: University Paris Descartes (1997)
- Hepatology and Gastroenterology residency,
- Chief residency at the Necker-Enfants Malades University and
- Molecular enzymology fellowship in Henri Mondor hospital.
- Head of the Liver Department at Necker Hospital (2004-2006) and Cochin Hospital (after 09.2006)
- Head of group 36 Inserm U1016, Cochin Institute
- Institut Pasteur: co-director of UMS20 since April 2014
- Head of the center of Translational Research (January 2015)
Collective activities
- ANRS/Inserm: Head of AC24 (therapeutic trials)(2000-2005)
- PI of the Hepather cohort (>2012)
- director of the Center of Translationnal Research of Institut Pasteur since 2015.
Publications
Télécharger-
2018Development and clinical validation of the Genedrive point-of-care test for qualitative detection of hepatitis C virus, Gut 2018 Apr;.
-
2018Parallel derivation of isogenic human primed and naive induced pluripotent stem cells, Nat Commun 2018 01;9(1):360.
-
2017An in vitro diagnostic certified point of care single nucleotide test for IL28B polymorphisms, PLoS ONE 2017;12(9):e0183084.
-
2017Hepatitis E virus-induced primary cutaneous CD30(+) T cell lymphoproliferative disorder, J. Hepatol. 2017 Dec;67(6):1334-1339.
-
2016Immunological and Antiviral Responses After Therapeutic DNA Immunization in Chronic Hepatitis B Patients Efficiently Treated by Analogues, Mol. Ther. 2014 Mar;22(3):675-684.
-
2016HCVerso1 and 2: faldaprevir with deleobuvir (BI 207127) and ribavirin for treatment-naïve patients with chronic hepatitis C virus genotype-1b infection, Clin Exp Gastroenterol 2016;9:351-363.
-
2016Treatment With Ledipasvir-Sofosbuvir for 12 or 24 Weeks in Kidney Transplant Recipients With Chronic Hepatitis C Virus Genotype 1 or 4 Infection: A Randomized Trial, Ann. Intern. Med. 2017 Jan;166(2):109-117.
-
2016Hepatitis B virus reactivation in patients with solid tumors receiving systemic anticancer treatment, Ann. Oncol. 2016 Dec;27(12):2172-2184.
-
2016Risk of cirrhosis-related complications in patients with advanced fibrosis following hepatitis C virus eradication, J. Hepatol. 2016 Oct;.
-
2016Antiviral Treatment of HCV-Infected Patients with B-Cell Non-Hodgkin Lymphoma: ANRS HC-13 Lympho-C Study, PLoS ONE 2016;11(10):e0162965.
-
+Voir la liste complète de publications